Tablets India Limited
Ipriflavone based nutraceuticals
Profile of Tablets (India) Limited
Tablets (India) Limited (TIL) is the Pharmaceutical Division of the Jhaver Group, a South India based industrial conglomerate, established in 1894, which has diversified business interests such as Agro-chemicals, Pesticides, Zip fasteners, Protective garments, Software, etc. and the groupís annual turnover is about USD 200 million.
TIL is a leader in India in the nicheí segments of Parenteral & Enteral nutrition, Probiotic and herbal based pharmaceutical formulations with an annual turnover of about USD 50 million. TIL has strategic technical collaborations with Roussel Morishita Pharmaceutical, Ajinomoto, Kotobuki Pharmaceutical, Toa Pharmaceutical all from Japan, F. Hoffman-la-Roche, Chr. Hansen, Biopole, BioGaia all from Europe and Novozymes Biologicals Inc. from USA, in the fields of Amino Acids, Specialized Probiotics, Life saving Injectables, Immunity building Nutritionals, Water and Soil Probiotics, etc.
TIL has established its leadership role in therapeutic segments: Metabolic disorders, Gastrointestinal ailments, Gynecological conditions, Post surgical management, Respiratory ailments, etc.
In India TILís 600 strong Marketing Field Force meets over 150, 000 Medical Doctors each month in every branch of specialty. Their prescriptions are serviced by over 100, 000 drug stores through a network of 1400 stockists. Recently TIL has also ventured into Animal Health Care to cater to the Aquaculture market.
With a strategic intent to increase its global presence, TIL has established Export activities and is present in 42 countries around the world with registered products.
TIL has four different manufacturing facilities, which are GMP certified as per WHO norms, SGS certified by the Societeí Generale Da Surveillance, S.A. Geneva and are accredited as ISO 9001 companies.
The Research & Development facility of TIL is recognized by the Ministry of Science & Technology, Govt. of India. By developing innovative solutions to difficult technical problems, TIL has been able to introduce a number of first time in the country amino acid, probiotic and herbal formulations.
The efforts of TILís marketing network is supported by a number of Medical and Pharmaceutical Scientists in Clinical Research, who develop path-breaking Pharmacological and Clinical Documentation and by closely working with Medical Universities, Hospitals and Academic Institutions throughout India.
TIL continues with its interest to look for further strategic technical alliances and business associations through focused in-licensing and TIL invites like minded partnerships for newer pharmaceutical and nutraceutical formulations.
TIL also offers its well equipped manufacturing facilities for toll / contract manufacturing of pharmaceutical / nutraceutical formulations and is scouting for partners.